Heynckes, S., Daka, K., Franco, P., Gaebelein, A., Frenking, J. H., Doria-Medina, R., . . . Heiland, D. H. (2019). Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme. BMC Cancer.
Styl ChicagoHeynckes, Sabrina, et al. "Crosslink between Temozolomide and PD-L1 Immune-checkpoint Inhibition in Glioblastoma Multiforme." BMC Cancer 2019.
Citace podle MLAHeynckes, Sabrina, et al. "Crosslink between Temozolomide and PD-L1 Immune-checkpoint Inhibition in Glioblastoma Multiforme." BMC Cancer 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..